Gil Beyen

Gil Beyen was the founder of TiGenix NV, holding the title of MD, Executive Director & Chief Business Officer in 2013.
Current jobs include Chief Executive Officer at Montis Biosciences BV since 2023, Executive Chairman at Erytech Pharma, Inc. since 2016, Vice Chairman at PHAXIAM Therapeutics SA since 2023, Director at Waterleau Technics NV, Co-Managing Director at Axxis V&C BV, Director at FlandersBio vzw, Director at Belgian Association for Bioindustries, Director at Ecloosion SA, Director at Novadip Biosciences SA since 2014, and Commissioner at Vlaams Instituut voor Biotechnologie - Flanders Institute.
Former jobs include Chairman & Chief Executive Officer at ERYTech Pharma SA from 2012 to 2019, Director at Bio.
Be SA, Head-Life Sciences Division at Arthur D.
Little, Inc., Manager at Mr. Beyen BVBA, and Head-Life Sciences Division at Arthur D.
Little Benelux NV from 1990 to 2002.
Education includes an MBA from The University of Chicago in 1990, a graduate degree from Katholieke Universiteit Leuven, and a graduate degree from Université Catholique de Louvain in 1984.